Loading clinical trials...
Loading clinical trials...
Postoperative Pain Management in Rhinoplasty: A Randomized Controlled Trial
The primary purpose of the study is to determine adequacy of postoperative pain control after nasal surgery in patients prescribed Acetaminophen (325mg) + Hydrocodone (5mg) compared to Acetaminophen(325mg) + Ibuprofen (200mg)for a period of 5 days after nasal surgery. To assess the degree of pain, the participants will score the intensity of their pain on a visual analog scale(VAS)of 0-100points (0- no pain and 100- most severe pain), preoperatively and postoperatively (to be documented before each dose) for the duration of the prescribed medications . Additionally, the study will also seek to track: 1. The total number of pills each patients consume from the prescribed 5 day regimen. 2. Any associated side effects. 3. Additional pain medications prescribed in case of inadequate pain control, postoperatively.
From this study, the investigators hope to learn the following: 1. Is adequate postoperative pain management after nasal surgery achieved with opioid or non-opioid drugs? 2. If opioid drugs are required for adequate pain control postoperatively, is it possible to reduce the number of days the drugs are prescribed for? 3. What are the common side effect profiles of the included drugs? In light of the current opioid epidemic in the country, it is important the the physicians explore the utility of drugs other than opioids for adequate postoperative pain management. Also, reducing the dosage and/or number of prescribed opioid drugs lessens the propensity for misuse of physician prescribed opioid medications.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Facial Plastic and Reconstructive Surgery Clinic
Stanford, California, United States
Start Date
August 9, 2019
Primary Completion Date
November 14, 2024
Completion Date
July 17, 2025
Last Updated
December 3, 2025
159
ACTUAL participants
Norco 5Mg-325Mg Tablet
DRUG
Tylenol 325Mg Caplet
DRUG
Ibuprofen 200 mg
DRUG
Lead Sponsor
Stanford University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions